June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Efficiency of gene therapy via intravitreal injection in primate cones
Author Affiliations & Notes
  • Michelle M Giarmarco
    Ophthalmology, University of Washington, Seattle, Washington, United States
  • Rachel Barborek
    Ophthalmology, University of Washington, Seattle, Washington, United States
  • Jessica Rowlan
    Ophthalmology, University of Washington, Seattle, Washington, United States
  • Dragos Rezeanu
    Ophthalmology, University of Washington, Seattle, Washington, United States
  • Briyana Bembry
    Ophthalmology, University of Washington, Seattle, Washington, United States
  • Jay Neitz
    Ophthalmology, University of Washington, Seattle, Washington, United States
  • Maureen Neitz
    Ophthalmology, University of Washington, Seattle, Washington, United States
  • James A Kuchenbecker
    Ophthalmology, University of Washington, Seattle, Washington, United States
  • Footnotes
    Commercial Relationships   Michelle Giarmarco None; Rachel Barborek None; Jessica Rowlan None; Dragos Rezeanu None; Briyana Bembry None; Jay Neitz None; Maureen Neitz None; James Kuchenbecker None
  • Footnotes
    Support  NIH NEI P30-EY001730
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 2586 – F0469. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Michelle M Giarmarco, Rachel Barborek, Jessica Rowlan, Dragos Rezeanu, Briyana Bembry, Jay Neitz, Maureen Neitz, James A Kuchenbecker; Efficiency of gene therapy via intravitreal injection in primate cones. Invest. Ophthalmol. Vis. Sci. 2022;63(7):2586 – F0469.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Intravitreal delivery of gene therapy vectors to the retina carries lower risk of adverse events compared to subretinal injections, but has thus far exhibited less therapeutic potential in animal studies. We developed a new adeno-associated virus (AAV) vector for intravitreal delivery of genes to cone photoreceptors. The virus carries an expression cassette with a cDNA encoding an engineered opsin fused to the gene for green fluorescent protein (GFP) under the control of regulatory elements directing expression to long- and middle-wavelength (L/M) cone photoreceptors. The purpose of this study was to evaluate the expression pattern of the opsin-GFP fusion protein after intravitreal injection of the vector in a primate eye.

Methods : The expression cassette was packaged in the 7m8 AAV capsid and 8.5 x 1010 viral genomes in a volume of 50 microliters was injected into the vitreous of an adult macaque eye. The eye was harvested 5 weeks after the injection and retinal cryosections were labeled with antibodies against short-wavelength (S) and L/M opsin. Following confocal imaging, volumes of fovea (400 µm wide, 20 µm deep) were analyzed in TrakEM2 to count individual GFP-expressing, S, and L/M cones.

Results : GFP fluorescence was confined to the fovea. Across the fovea around 25% of cones expressed GFP, with expression highest at the center. GFP was localized primarily in the outer segments, and diffusely along the plasma membrane. While the majority of transduced cones were L/M, surprisingly a small fraction (~5%) were S cones.

Conclusions : A gene therapy vector designed for intravitreal delivery directed robust expression of an engineered opsin to foveal cones in a primate. This finding is promising for the next phase of ocular gene therapy in humans.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

 

Confocal image of a foveal section from a primate retina 5 weeks after intravitreal injection of 7m8_AAV carrying the gene for an opsin-GFP fusion targeted to L/M cones. Transduced cones express GFP (green) and primarily L/M opsin (magenta); a small portion of transduced cones express S opsin (blue). Presented image is maximum intensity projected over a depth of 20 µm.

Confocal image of a foveal section from a primate retina 5 weeks after intravitreal injection of 7m8_AAV carrying the gene for an opsin-GFP fusion targeted to L/M cones. Transduced cones express GFP (green) and primarily L/M opsin (magenta); a small portion of transduced cones express S opsin (blue). Presented image is maximum intensity projected over a depth of 20 µm.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×